miacalcic 100i.u ampoules

miacalcic 100i.u ampoules
miacalcic 100i.u ampoules


Article Content:

    Information about miacalcic ampoules effective for the treatment of osteoporosis after menopause in menopause in women, as it is considered the early treatment of cases of hypercalcemia and treats moderate Paget's patients, because it contains the active ingredient calcitonin, which regulates calcium levels in the blood.

    Ingredients for miacalcic ampoules

    miacalcic ampoules are composed on the active ingredient calcitonin, as they regulate calcium levels in the blood and regulate the excretion of calcium, phosphorus and magnesium in the kidneys.

    About miacalcic Ampoules

    • Drug Category : Endocrinology
    • Drug classification : Thyroid metabolic agent
    • Active ingredient : Calcitonin
    • Indications : Treatment of osteoporosis after menopause

    Pharmacist Nada Mohamed Mostafa
    Scientific Degree: pharmacist
    Country: Egypt

    Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

    A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

    Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

    Published Date: 10 April 2025

    Source 1 : Drugs Calcitonin
    you should ask your doctor before taking this medicine